FDA approves once-daily Zerit
BY Advocate.com Editors
January 03 2003 1:00 AM ET
The Food and Drug Administration on Tuesday approved a new, extended-release form of the HIV nucleoside reverse transcriptase inhibitor Zerit (d4T), which will be marketed as Zerit XR by drugmaker Bristol-Myers Squibb. The new formulation can be taken just once a day. Data from clinical trials of the medication show that it is as effective as the standard twice-daily dosing of d4T and that reducing the pill burden may help people with HIV better stick to their anti-HIV drug regimens.
- More Events Cancel Over Gay Hotel Owner's Ted Cruz Dinner Party
- Kris Humphries Blames Vague Tweet, Supports Bruce Jenner
- Check Out The Enormous Support for Bruce Jenner from Celebs on Twitter
- Gay High-Schooler Gets Date for Prom — With Straight Best Friend
- Bruce Jenner: 'I'm A Woman'
- 7 Institutions of HIV Infection